Suzhou Yangen Biotech Co., Ltd takes technological innovation as its core driving force, conducts process innovation through technologies such as asymmetric metal-catalyzed hydrogenation, bio-enzyme catalysis, and flow chemistry, and is committed to providing customers with high-end pharmaceutical intermediates and CRDMO services.